By Regulatory Approvals — FDA approves nogapendekin alfa inbakicept plus BCG for papillary-only BCG-unresponsive NMIBC Urology Times
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 14, 2026.